Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-07 1:15 pm Purchase | 13G | ATHIRA PHARMA INC ATHA | BML Investment Partners L.P. | 2,484,445 6.500% | 2,484,445 (New Position) | View |
| 2024-11-07 12:50 pm Purchase | 13G | ESSA Pharma Inc. EPIX | BML Investment Partners L.P. | 4,183,223 9.400% | 4,183,223 (New Position) | View |
| 2024-10-09 11:40 am Purchase | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | BML Investment Partners L.P. | 447,815 3.500% | 447,815 (New Position) | View |
| 2024-09-25 7:14 pm Purchase | 13G | Achilles Therapeutics plc ACHL | BML Investment Partners L.P. | 4,100,002 9.970% | 4,100,002 (New Position) | View |
| 2024-09-16 4:42 pm Purchase | 13G | ORAMED PHARMACEUTICALS INC. ORMP | BML Investment Partners L.P. | 2,048,634 5.000% | 2,048,634 (New Position) | View |
| 2024-08-28 4:42 pm Purchase | 13G | AADI BIOSCIENCE INC AADI | BML Investment Partners L.P. | 1,383,817 5.600% | 1,383,817 (New Position) | View |
| 2024-08-14 9:23 pm Purchase | 13G | TALIS BIOMEDICAL CORP COM TLIS | BML Investment Partners L.P. | 203,569 11.200% | 69,484 (+51.82%) | View |
| 2024-08-14 9:00 pm Purchase | 13G | AN2 Therapeutics Inc. ANTX | BML Investment Partners L.P. | 5,749,432 19.300% | 1,500,000 (+35.30%) | View |
| 2024-08-14 8:44 pm Purchase | 13G | TALIS BIOMEDICAL CORP COM TLIS | BML Investment Partners L.P. | 134,085 7.400% | 134,085 (New Position) | View |
| 2024-08-12 4:48 pm Purchase | 13G | AN2 Therapeutics Inc. ANTX | BML Investment Partners L.P. | 4,249,432 14.200% | 4,249,432 (New Position) | View |
| 2024-07-22 4:24 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners L.P. | 2,206,346 10.600% | 1,065,346 (+93.37%) | View |
| 2024-05-21 10:12 am Purchase | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | BML Investment Partners L.P. | 3,692,963 11.000% | 1,998,734 (+117.97%) | View |
| 2024-05-21 10:01 am Purchase | 13G | TECTONIC THERAPEUTIC INC TECX | BML Investment Partners L.P. | 5,168,262 11.500% | 766,635 (+17.42%) | View |
| 2024-04-29 4:10 pm Sale | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners L.P. | 1,141,000 5.500% | -3,713,252 (-76.49%) | View |
| 2024-04-02 4:36 pm Purchase | 13G | INSTIL BIO INC TIL | BML Investment Partners L.P. | 346,190 5.300% | 346,190 (New Position) | View |
| 2024-03-19 4:29 pm Purchase | 13G | Cyteir Therapeutics Inc. CYT | BML Investment Partners L.P. | 3,818,464 10.600% | 348,456 (+10.04%) | View |
| 2024-02-08 11:14 am Purchase | 13G | Aclaris Therapeutics Inc. ACRS | BML Investment Partners L.P. | 9,395,934 13.300% | 4,895,934 (+108.80%) | View |
| 2024-02-07 2:11 pm Purchase | 13G | TOURMALINE BIO INC TRML | BML Investment Partners L.P. | 245,500 1.000% | 245,500 (New Position) | View |
| 2024-02-07 1:40 pm Purchase | 13G | Cyteir Therapeutics Inc. CYT | BML Investment Partners L.P. | 3,470,008 9.600% | 734,035 (+26.83%) | View |
| 2024-02-07 1:18 pm Sale | 13G | SURROZEN INC SRZN | BML Investment Partners L.P. | 0 0.000% | -1,669,037 (Position Closed) | View |